- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18:08 | Sanofi loses vaccines chief Loew to Ipsen amid global attention on its COVID-19 project | ||
| 17:08 | FDA pushes metformin recalls for 5 drugmakers after carcinogen contamination | ||
| 15:08 | FiercePharmaAsia-CanSino's COVID-19 vaccine data; Takeda's new Alunbrig nod; GSK-Samsung deal | ||
| 14:08 | ASCO: In stomach cancer, AstraZeneca and Daiichi's Enhertu goes where Roche's Kadcyla couldn't | ||
| 14:08 | ASCO: Gilead CAR-T med Yescarta delivers 93% response rate in slow-growing lymphoma | ||
| Do | ASCO: Pfizer, Merck KGaA's Bavencio lines up for bladder cancer edge with survival win | ||
| Do | FDA finds likely carcinogen in the common diabetes drug metformin. Will recalls follow? | ||
| Do | Immunomedics' new CEO hits COVID-19 exit, takes $1M on his way out | ||
| Do | Roche hooks up with Gilead for Actemra-remdesivir combo trial in COVID-19 | ||
| Do | GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple COVID-19 partners | ||
| Do | AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica production deal | ||
| Do | Thermo Fisher continues global expansion push with CSL Behring biologics plant lease | ||
| Mi | Want COVID-19 herd immunity? Get 40% of population vaccinated, says ex-FDA chief Gottlieb | ||
| Mi | What's needed to prove a COVID-19 vaccine works-and are top players across 3 continents there yet? | ||
| Mi | Novavax snares $167M buyout to rapidly scale up COVID-19 vaccine manufacturing | ||
| Mi | Trump, amid COVID-19 response, touts new insulin savings program | ||
| Mi | Novartis' repurposed leukemia drug tops Sanofi's Aubagio in MS study weeks ahead of FDA verdict | ||
| Mi | FDA blasts Altaire for 'tape and foil' contraptions, data flaws at sterile eye drug plant | ||
| Mi | Bristol Myers Squibb's Opdivo, Yervoy score another lung cancer OK, this time alongside chemo | ||
| Di | Takeda's Alunbrig scores nod for earlier lung cancer use, but a Roche showdown awaits | ||
| Di | Trailing Big Pharma peers, Merck inks deals to advance COVID-19 drugs, vaccines | ||
| Di | No more legal headache for Bayer as it nears $10B Roundup settlement: report | ||
| Di | Detailed COVID-19 data for Gilead's remdesivir are finally here, confirming its benefits and limitations | ||
| Di | Sanofi plans to unload a $13B Regeneron stake. Is a rare disease buyout next? | ||
| Di | Sanofi, Regeneron boost Dupixent's megablockbuster quest with latest trial win |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
